Letters, Testimony & Comments

BIO submits letters, testimony, and comments to government and regulatory bodies throughout the United States and around the world.

Featured Letters, Testimony, & Comments
Notice of Request for Public Comments on Section…
The Biotechnology Innovation Organization (BIO) offers this submission in response to the request by the Department of Commerce for comments on section 232 national security investigation of imports of pharmaceuticals and pharmaceutical ingredients…
BIO Letter to Congressional Leadership on the…
One thing that we can all agree on is the need to give our children a fighting chance so they can lead long and productive lives. That is why it is critical to pass the bipartisan Give Kids a Chance Act and ensure the Pediatric Priority Review…
John F. Crowley's One-Year Anniversary Letter to…
Dear Colleagues, This month marks my one-year anniversary as BIO's CEO. Like most of us in biotech, this post has been a labor of love. At no time in my 25-year career in this industry have I ever witnessed such awe-inspiring science. Today, we…
All Letters, Testimony & Comments
  • Show All
Search
Results
March 10, 2016
Presentation at International Science Attachés Briefing
March 10, 2016
Cloning is an assisted reproductive technique that produces an animal that is an identical twin of an existing animal.
March 10, 2016
Comments concerning China's compliance with WTO commitments.
March 10, 2016
BIO's Issue Paper in Response to Report Criticizing Herbicide and Pesticide Use and Biotech Seed Prices.
March 10, 2016
BIO urges support from the U.S. Department of Agriculture for FDA’s release of the final risk assessment on animal cloning.
March 10, 2016
NIST includes biomanufacturing as an area of "critical national need" for 2010 TIP competition.
March 10, 2016
Centers for Disease Control & Prevention, Clinician Outreach and Community Activity (COCA) Conference Call July 27, 2010.
March 10, 2016
May 2010 National Security Strategy from the White House
March 10, 2016
NIST clarifies that device development is not a focus of 2010 TIP competition.
March 10, 2016
The National Vaccine Program was established in 1986 to achieve optimal prevention of infectious diseases through immunization and optimal prevention of adverse reactions to vaccines.